{"name":"Chembio Diagnostics","slug":"chembio","ticker":"CEMI","exchange":"NASDAQ","domain":"chembio.com","description":"Chembio Diagnostics is a biotechnology company focused on the development and commercialization of point-of-care diagnostic tests for infectious diseases. The company's key products include DPP HIV 1/2, DPP Syphilis, and DPP Zika. Chembio Diagnostics operates in the diagnostics sector, targeting the infectious disease market.","hq":"Hauppauge, NY","founded":0,"employees":"","ceo":"Richard Eberly","sector":"Diagnostics / Infectious Disease","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$35M","metrics":{"revenue":49521923,"revenueGrowth":3.6,"grossMargin":0,"rdSpend":7067852,"netIncome":-23290657,"cash":62611405,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"DPP HIV 1/2 patent cliff ($10.0M at risk)","drug":"DPP HIV 1/2","type":"patent_expiry","sentiment":"negative"},{"date":"2030-06-01","label":"DPP Syphilis patent cliff ($5.0M at risk)","drug":"DPP Syphilis","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Chembio Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Chembio Diagnostics reported its fourth quarter and full year 2023 financial results, with revenue of $13.4 million and a net loss of $4.3 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Chembio Diagnostics Announces Collaboration with the Bill and Melinda Gates Foundation","summary":"Chembio Diagnostics announced a collaboration with the Bill and Melinda Gates Foundation to develop and distribute point-of-care diagnostic tests for infectious diseases in low- and middle-income countries.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE95dzRxbGk2bmpmc1FZcG9kM3I4MGZhX3FMTWN5aDN1XzRVNmVBN0gyaTE3c21MNUxpUG5MUHk3V1RCYlk1a0hscXhYSUI4Tkdyb1RR?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"CEMI Stock Price, News & Analysis | Chembio Diagnostics - Stock Titan","headline":"CEMI Stock Price, News & Analysis | Chembio Diagnostics","sentiment":"neutral"},{"date":"2023-05-01","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC: SC 13D","headline":"SC 13D Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQbGo2VVBHNlJpa1FweklmRzFpZ0VaM01oSHpoZE9kUXdERnVta25vbTZQbDh2QTU3NUhRbC13QXhPNXZhNTBwMGNwVlQ2OWVvZ0RYVG1qanp0NFJuQjB1Qmt0QTUzSUVzMlZfN2VrcUN1VVhyNDR6Q3doNHIwVk5WNVZKQUptYzdI?oc=5","date":"2020-12-02","type":"pipeline","source":"MassDevice","summary":"Chembio lands $12.7M from BARDA for point-of-care test - MassDevice","headline":"Chembio lands $12.7M from BARDA for point-of-care test","sentiment":"neutral"}],"patents":[{"drugName":"DPP HIV 1/2","drugSlug":"hiv-1/2","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":10000000},{"drugName":"DPP Syphilis","drugSlug":"syphilis","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":5000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Abbott Laboratories","Roche Holding","Becton Dickinson and Company"],"therapeuticFocus":["Infectious Diseases"],"financials":{"source":"sec_edgar+yahoo","revenue":49521923,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":49521923,"period":"2022-12-31"},{"value":47818452,"period":"2021-12-31"},{"value":47818452,"period":"2021-12-31"},{"value":32470197,"period":"2020-12-31"},{"value":32470197,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":7067852,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-23290657,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":62611405,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}